September 7, 2005 - New safety information (PDF - 178 KB) regarding SEREVENT
August 15, 2003 - Important safety information (PDF - 84.2 KB) regarding SEREVENT (salmeterol xinafoate) inhalation aerosol
Patient information:
October 4, 2005 - safety information about a class of asthma drugs known as long-acting beta-2 agonists
September 4, 2003 - Important safety information (PDF - 17.6 KB) regarding SEREVENT (salmeterol xinafoate) inhalation aerosol
You are leaving our website
The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.